- Facultat de Medicina
Centro
![Foto de - Facultat de Medicina](/img/noimage.png)
![Foto de Hospital Universitario de Canarias](/img/noimage_org.png)
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Canarias (39)
2024
-
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023
Neurologia, Vol. 39, Núm. 2, pp. 196-208
-
Crucial role of the NSE1 RING domain in Smc5/6 stability and FANCM-independent fork progression
Cellular and Molecular Life Sciences, Vol. 81, Núm. 1
-
Modified Oblique Lobenhoffer (MOL) approach for posterolateral and posteromedial column access in tibial plateau fractures: a detailed cadaveric anatomical study
Journal of Orthopaedics and Traumatology, Vol. 25, Núm. 1
-
Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma
Blood, Vol. 143, Núm. 7, pp. 597-603
2023
-
Data analysis from the Spanish Registry of Cardiac Surgery (RECC) 2021-2022
Cirugia Cardiovascular, Vol. 30, Núm. 6, pp. 335-347
-
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666
2022
-
Antiplatelet therapy at discharge and long-term prognosis in Takotsubo syndrome: Insights from the Spanish National Registry (RETAKO)
Revista Portuguesa de Cardiologia, Vol. 41, Núm. 11, pp. 919-927
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
JAMA Network Open, Vol. 5, Núm. 1
-
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study
Cancers, Vol. 14, Núm. 24
-
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study
Neuroendocrinology, Vol. 112, Núm. 1, pp. 88-100
-
Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell
Nefrologia, Vol. 42, Núm. 6, pp. 645-655
2021
-
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia
Blood, Vol. 137, Núm. 14, pp. 1879-1894
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study
ESC Heart Failure, Vol. 8, Núm. 6, pp. 4820-4831
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials
Hematological Oncology, Vol. 39, Núm. 4, pp. 529-538
-
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
Neurologia, Vol. 36, Núm. 1, pp. 50-60
2020
-
Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024